The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosis

Published:2022-07 Issue: Volume:63 Page:103837
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Glasmacher Stella A^ORCID,Kearns Patrick KA,Hassan Zackary,Connick Peter,Tauber Simone,Reetz Kathrin,Foley Peter,Chandran Siddharthan

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference51 articles.

1. Diagnose Und Therapie der Multiplen Sklerose, Neuromyelitis-optica-Spektrum-Erkrankungen und MOG-IgG-assoziierten Erkrankungen, S2k-Leitlinie;Hemmer,2021

2. Depression, anxiety and stress severities in multiple sclerosis patients using injectable versus oral treatments;Al-Hussain;J. Comp. Eff. Res.,2017

3. Disease-modifying therapy aids cognition in multiple sclerosis;Amato;Nat. Rev. Neurol.,2020

4. Fatigue and affective manifestations in multiple sclerosis-a cluster approach;Ayache;Brain Sci.,2019

5. The concept of symptom cluster;Barsevick;Semin. Oncol. Nurs.,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sleep Disturbance and Related Factors in the Patients with Relapsing-Remitting Multiple Sclerosis;Acta Neurologica Scandinavica;2024-04-04

2. “No association between disease modifying treatment and fatigue in multiple sclerosis”;Multiple Sclerosis and Related Disorders;2023-11

3. Identification and management of subclinical disease activity in early multiple sclerosis: a review;Journal of Neurology;2023-10-21

4. Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review;Bioengineering;2023-07-18

5. Sleep counts! Role and impact of sleep in the multimodal management of multiple sclerosis;Journal of Neurology;2023-03-11